At Biosfer Teslab, scientific innovation and translational research are the cornerstones that drive our commitment to more precise and personalized medicine. Throughout 2025, we have strengthened this commitment through the development of new R&D&I projects, the publication of outstanding scientific articles, participation in European initiatives, and active collaboration with the international scientific community.
This newsletter highlights the main milestones achieved during the year, reflecting our ongoing effort to transform scientific knowledge into solutions with clinical impact. From advances in metabolomics, lipidomics, and multi-omics approaches, to participation in international conferences and collaborative projects, each achievement represents another step toward improving the diagnosis, prevention, and treatment of complex diseases.
We sincerely thank our collaborators, clients, and partners for their trust and support, which make it possible for us to continue advancing our mission of generating knowledge, fostering innovation, and contributing to the progress of precision medicine.
